Skip to Main Content

Paper Details

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update.
J Clin Oncol
128
2022
Breast Cancer, ER, ER+, ER+ and HER2- breast cancer, Early-Stage Breast Cancer, HER2, HER2-) breast cancer, HER2-positive or triple-negative breast cancer, Ki67, breast, breast cancer, early-stage breast cancer, estrogen, estrogen receptor, human epidermal growth factor receptor 2, patient, patients
Author NameAffiliation
Deborah Collyar
Lajos PusztaiYale Cancer Center
Antonio C WolffJohns Hopkins University
Vered StearnsJohns Hopkins University
  • 1 - 4

Datasets

Release 1.2